Thu, March 2, 2023
Wed, March 1, 2023
Tue, February 28, 2023

Vamil Divan Initiated (ANIP) at Strong Buy and Held Target at $55 on, Mar 1st, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. g-buy-and-held-target-at-55-on-mar-1st-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Vamil Divan of Guggenheim, Initiated "ANI Pharmaceuticals, Inc." (ANIP) at Strong Buy and Held Target at $55 on, Mar 1st, 2023.

Vamil has made no other calls on ANIP in the last 4 months.



There is 1 other peer that has a rating on ANIP. Out of the 1 peers that are also analyzing ANIP, 0 agree with Vamil's Rating of Hold.



This is the rating of the analyst that currently disagrees with Vamil


  • Oren Livnat of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $50 on, Tuesday, February 21st, 2023

Publication Contributing Sources